夏伟梁 - 上海交通大学 - 生物医学工程学院

个人简介

夏伟梁博士，长聘教授，博士生导师，致远学院副院长, 癌基因及相关基因国家重点实验室兼职课题组长。曾于清华大学、香港大学、美国洛克菲勒大学及加州大学旧金山分校学习和深造。2008年底全职加入交大Med-X研究院从事生物医学研究和教学。入选上海市科委启明星、上海交大晨星学者、唐立新优秀学者，获教育部“基础学科拔尖学生培养计划2.0”荣誉奖项-优秀管理人员奖、中华医学科技奖二等奖、上海交通大学教书育人集体奖二等奖及教学成果奖特等奖等荣誉。立足医工交叉，聚焦肺癌等难治疾病的机制和诊疗新靶点，研究FGF/FGFR等生长因子信号促进肺癌进展和外泌体生物学及诊疗应用。主持科技部973课题、国家自然科学基金委、医工交叉重点等基金十余项。在Cell Death & Differentiation、PNAS、Oncogene、Protein Cell、 Biomaterials等发表约110篇学术论文，H-因子43。科研项目科技部973项目课题，国家自然科学基金委面上项目，上海交通大学医工交叉重点项目

研究领域

肿瘤进展、治疗抵抗的机制及新靶点发现（Mechanisms of lung/prostate cancer progression and treatment resistance, and discovery of novel targets）; 外泌体生物学及其应用（biology of exosome and applications）; FGF/FGFR和Sirtuin在肿瘤和组织修复的作用（role of FGF/FGFR and sirtuin in cancer and tissue repair）。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Cheng Y, Lu X, Li F, Chen Z, Zhang Y, Han Q, Zeng Q, Wu T, Li Z, Lu S, Williams C, Xia W*.NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation Protein Cell (accepted) 2. Han Q, Xie QR, Li F, Cheng Y, Wu T, Zhang Y, Lu X, Wong AST, Sha J*, Xia W*. Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer. Theranostics. 2021;11:6526-6541. 3. Li F, Li Z, Han Q, Chen Y, Ji W, Yang Y, Lu S, Xia W*. Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104. Oncogene. 2020; 37:3507–3521. 4. Li F, Li X, Li Z, Ji W, Lu S, Xia W*. βKlotho is identified as a target for theranostics in non-small cell lung cancer. Theranostics. 2019; 9:7474-7489. 5. Yan L, Li H*, Xia W*. Bioglass could increase cell membrane fluidity with ion products to develop its bioactivity. Cell Prolif. 2020;53: e12906. 6. Cheng Y, Zeng Q, Han Q, Xia W*. Effect of pH, temperature and freezing-thawing on quantity changes and cellular uptake of exosomes. Protein Cell. 2019; 10:295-299. 7. Liu J, Liu Y, Shao J, Li Y, Qin L, Shen H, Xie Y, Xia W*, Gao WQ*. Zeb1 is important for proper cleavage plane orientation of dividing progenitors and neuronal migration in the mouse neocortex. Cell Death Differ.2019; 26:2479-2492. 8. Wang K, Ji W, Yu Y, Li Z, Niu X, Xia W*, Lu S*.FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer. Oncogene. 2018;37:5340-5354. 9. Lu T, Li Z, Yang Y, Ji W, Yu Y, Niu X, Zeng Q, Xia W*, Lu S*. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer. Cancer Lett. 2018; 423:36-46. 10. Yang X, Geng K, Zhang Y, Zhang J, Shao J, Xia W*. Sirt3 deficiency impairs neurovascular recovery in ischemic stroke. CNS Neurosci Ther.2018;24:775-783. 11. Zhang T, Yang X, Liu T, Shao J, Fu N, Yan A, Geng K, Xia W*.Adjudin-preconditioned neural stem cells enhance neuroprotection after ischemia reperfusion in mice. Stem Cell Res Ther. 2017, 8:248. 12. Yang X, Geng K, Zhang J, Zhang Y, Shao J, Xia W*. Sirt3 Mediates the Inhibitory Effect of Adjudin on Astrocyte Activation and Glial Scar Formation following Ischemic Stroke. Front Pharmacol. 2017 Dec 22;8:943. 13. Xia W*, Geng K. A sirtuin activator and an anti-inflammatory molecule—multifaceted roles of adjudin and its potential applications for aging-related diseases. Semin Cell Dev Biol.2016;59:71-78. 14. Shao J, Yang X, Liu T,Zhang T,Xie QR, Xia W*. Autophagy induction by SIRT6 is involved in oxidative stress-induced neuronal cell death. Protein Cell. 2016, 7:281-290. 15. Chen Y, Gu H*, Zhang DS, Li F, Liu T, Xia W*.Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier.Biomaterials. 2014;35:10058-10069.

学术兼职

任中国生物医学工程学会、中国细胞生物学学会、美国癌症研究协会会员；Extracellular Vesicles and Circulating Nucleic Acids(EVCNA)编委，Frontiers in Oncology-Molecular and Cellular Oncology， Associate Editor。曾任中国细胞生物学学会第二届青年工作委员会委员、上海交通大学学术委员会委员（2016-2020年）。